Lp(a) and Apo-lipoproteins as predictors for diabetic retinopathy and its severity in patients with type 2 diabetes: A case-cohort study
Publication date: Available online 23 January 2020Source: Canadian Journal of DiabetesAuthor(s): Fatemeh Moosaie, Reza Mohamadhosseinzadeh Davatgari, Fatemeh Dehghani Firouzabadi, Sadaf Esteghamati, Niloofar Deravi, Alipasha Meysamie, Pegah Khaloo, Manouchehr Nakhjavani, Alireza EsteghamatiAbstract:AimsTo measure the relationship between serum Lp(a) and apolipoproteins and the risk of developing diabetic retinopathy(DR)Methods1057 patients with type 2 diabetes were divided into three groups and followed for five years: 637 patients without DR, 162 patients with non-proliferative DR (NPDR), and 163 patients with proliferative DR (PDR). The association between serum Lp (a) and apolipoproteins with NPDR and PDR was assessed by using univariate and multivariate regression analysis. The ROC analysis was measured based on the new cutoff values.ResultsThere was a positive relationship between Lp(a) and the presence of DR as well as a negative correlation between ApoA and DR (p value
TYPE 2 diabetes is a chronic condition that can be a precursor to more serious health problems so it is imperative to keep the condition in check. Lowering blood sugar levels helps to stabilise the condition and a particular cooking oil has been shown to facilitate this process.
AbstractSitagliptin attenuates left ventricular (LV) dysfunction and may improve oxygen uptake in animals. The effects of sitagliptin on oxygen uptake (VO2) and exercise hemodynamics have been unclear in patients with type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD). Thirty patients with T2DM and CAD were randomized into a sitagliptin (50 mg/day) or voglibose (0.6 mg/day) group. Patients underwent maximal cardiopulmonary exercise testing. VO2 and hemodynamics were evaluated at rest, anaerobic threshold and peak exercise. Resting LV diastolic function (E ’, peak early diastolic mitral annular velocity...
By Emily Reynolds Ensuring you’re well-informed before making a choice is, on the whole, a sensible thing to do. This is especially true of big decisions — just pretending you’ve read the terms and conditions of a new website might be okay, but we’re unlikely to be so lax about our health or finances. But could too much information lead us to make worse, not better, decisions? A study published in Cognitive Research: Principles and Implications suggests that sometimes that might be the case. Min Zheng and colleagues were motivated by advances in machine learning that have increased the informat...
CONCLUSIONS These results indicate that GDLP against T2DM-induced hepatic steatosis, oxidative stress, and inflammation by improving the Nrf2/HO-1 signaling pathway in db/db mice, suggesting the GDLP may serve as an effective strategy for in fatty liver treatment. PMID: 32245940 [PubMed - as supplied by publisher]
(Elsevier) A new study in the American Journal of Preventive Medicine, published by Elsevier, reports valuable new grip strength metrics that provide healthcare practitioners with an easy-to-perform, time-efficient screening tool for type 2 diabetes (T2DM).
Publication date: Available online 4 April 2020Source: Journal of Ayurveda and Integrative MedicineAuthor(s): Naresh Kumar P, Ragavendrasamy Balakrishnan, Vibhas Kana
ConclusionAndean adults showed greater odds of T2DM compared with Spanish native adults in Madrid, with variation observed by age and sex. These findings emphasize the need for studying immigrant populations in a disaggregated manner to implement specific clinical and preventive approaches.
TYPE 2 diabetes requires one to lead a healthy lifestyle to keep blood sugar levels under control. Since exercise plays a key role in controlling blood sugar levels, the current lockdown poses a threat to type 2 diabetes management. Luckily, there is a simple activity you can do from the comfort of your home that has proven to lower post-meal blood sugar levels.
Publication date: Available online 5 April 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Omid Asbaghi, Faezeh Fouladvand, Sajjad Moradi, Damoon Ashtary-Larky, Razieh Choghakhori, Amir Abbasnezhad
Authors: Popa A, Georgescu M, Popa SG, Nica AE, Georgescu EF Abstract Steadily, cancer is becoming the first cause of mortality, with over 9 million deaths estimated in 2018. Increasing evidence supports a direct association between obesity, type 2 diabetes mellitus (T2DM) and cancer, with a higher risk of cancer mortality especially for some of the most common malignancies, such as breast, colon, and rectal cancers. So far, several mechanisms underlying the cancer-diabetes relationship have been investigated revealing dysregulations of the insulin-insulin-like growth factor (IGF) system as the most important parad...